The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin
Journal of Thoracic Oncology (2011) - Comments
pubmed: 21270666  doi: 10.1097/jto.0b013e31820c9e3c  issn: 1556-0864  issn: 1556-1380 

Anjaiah Srirangam, Monica Milani, Ranjana Mitra, Zhijun Guo, Mariangellys Rodriguez, Hitesh Kathuria, Seiji Fukuda, Anthony Rizzardi, Stephen Schmechel, David G. Skalnik, Louis M. Pelus, David A. Potter